Equity futures were marginally higher after the close, slightly curtailing the session's mild losses as markets contend with light year-end volumes and a pullback in heavyweight tech and AI names that stalled last week's strong rally. Comments from various Fed members in minutes from the last FOMC meeting on the likelihood of future rate cuts continue to weigh on the markets as well.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER -iSpecimenup 36.9% after announcing the pricing of a $5.5M private placementOriental Riseup 23.8% after entering a non-binding letter of intent to acquire Hubei Daguan TeaOne Stop Systemsup 6.3% after agreeing to sell Bressner Technology to Hiper Euro for $22.4MDot Aiup 1.9% after saying it is not aware of any undisclosed material adverse events, has not executed any equity dilution transactions, and has not authorized any sales of company shares by officers or directors in connection with recent market activityLOWER -Smart Powerrdown 10.5% after filing to sell 16.36M shares of common stock for holders
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
